ITRYNOX-200

ITRACONAZOLE

ITRYNOX-200

COMPOSITIONSPECIFICATION
ITRACONAZOLE 200 MGPACKING10*10
PACKING TYPEALU-ALU
GST12%
MRP2600

Category:

DESCRIPTION

One of the triazole antifungal agents that inhibits cytochrome P-450-dependent enzymes resulting in impairment of ergosterol synthesis. It has been used against histoplasmosis, blastomycosis, cryptococcal meningitis & aspergillosis. [PubChem]

SIDE EFFECTS

For the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients: pulmonary and extrapulmonary blastomycosis, histoplasmosis, aspergillosis, and onychomycosis.

INDICATION

N/A